LOG IN

AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS

Versiunea din 18 septembrie 2024 15:40, autor: Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS listata cu simbolul US.AVDL ==Descriere companie== Avadel Pharmaceuticals plc (www.avadel.com) is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or cont...)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS listata cu simbolul US.AVDL

Descriere companieModificare

Avadel Pharmaceuticals plc (www.avadel.com) is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.

Grafic actiuni companieModificare

Ultimele stiri despre AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (US.AVDL)Modificare

Adus de la „https://wiki.tradeville.ro/index.php?title=AVADEL_PHARMACEUTICALS_PLC_SPON_ADR_EACH_REP_1_ORD_SHS&oldid=408103”